Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Gemphire Therapeutics Inc (GEMP)

8.24 -0.36 (-4.19%)

8/18/2017  4:00pm

Open:

8.53

Pre. Close:

8.60

High:

8.65

Low:

8.19

Volume:

61,915

Market Cap:

87.56M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

8.75 - 8.91

8.91 - 9.07

Low:

8.02 - 7.94

7.94 - 7.87

Close:

8.13 - 8.31

8.31 - 8.49

Technical analysis  (as of: 2017-08-18 4:40:13 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 18.80     One year: 25.22

Support:

Support1: 7.20    Support2: 5.99

Resistance:

Resistance1: 16.09    Resistance2: 21.59

Pivot:

12.29

Moving Averages:

MA(5): 8.56     MA(20): 14.11

MA(100): 12.16     MA(250): 10.87

MACD:

MACD(12,26): -2.03     Signal(12,26,9): -1.20

%K %D:

%K(14,3): 8.73     %D(3): 9.41

RSI:

RSI(14): 28.75

52-Week:

High: 21.59  Low: 7.20  Change(%): -17.6

Average Vol(K):

3-Month: 12561  10-Days 27143

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
GEMP has closed above bottom band by 30.4%. Bollinger Bands are 353% wider than normal. The large width of the bands suggest high volatility as compared to GEMP's normal range. The bands have been in this wide range for 36 bars. This is a sign that the current trend might continue.

Headline News

Mon, 07 Aug 2017 14:03:45 GMT
Gemphire Therapeutics Inc. (GEMP) Is Declining After Study Results Released

Mon, 07 Aug 2017 16:18:45 GMT
Mid-Day Market Update: NxStage Medical Surges Following Acquisition News ...

Fri, 10 Mar 2017 17:03:45 GMT
Gemphire Therapeutics to sell $12.5 million in stock

Tue, 30 May 2017 20:03:45 GMT
Gemphire Therapeutics Announces Departure of Its Chief Executive Officer Mina ...

Thu, 06 Oct 2016 10:01:50 GMT
Gemphire Therapeutics Appoints Lee Golden, MD, as Chief Medical Officer

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

10.60

Shares Float (M)

4.86

% Held by Insiders

% Held by Institutions

Shares Short (K)

206

Shares Short Prior Month (K)

287

Stock Financials

EPS

-2.760

EPS Est. Current Year

-2.780

EPS Est. Next Year

-2.100

EPS Est. Next Quarter

-0.590

Forward EPS

-2.160

Book Value (p.s.)

2.390

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-76.9

Return on Equity (ttm)

-211.5

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

Qtrly Earnings Growth

Operating Cash Flow (M)

-15.21

Levered Free Cash Flow (M)

-8.62

FoxReading.com

Valuation

P/E

-2.99

P/E Growth Ratio

-0.04

P/BV

3.45

P/S

P/CF

-5.74

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.